Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice

Gene Therapy

Volumn 14, Issue 20, 2007, Pages 1492-1501

  Ostrowski, L E ^a   Yin, W ^a   Diggs, P S ^a   Rogers, T D ^a   O'Neal, W K ^a   Grubb, B R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA ANALYSIS; SODIUM ABSORPTION; TRACHEA MUCOSA; WESTERN BLOTTING;

AMILORIDE; ANIMALS; CHLORIDE CHANNELS; CILIA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION; GENE THERAPY; HUMANS; IMMUNOPRECIPITATION; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NASAL MUCOSA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM CHANNEL BLOCKERS; TRACHEA; TRANSGENES; TREATMENT FAILURE;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 34848847214     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302994     Document Type: Article

References (46)

1. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene:cLoning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
2. Rommens JM, Iannuzzi MC, Kerem B-S, Drumm ML, Melmer G, Dean M et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989; 245: 1059-1065.
3. Griesenbach U, Geddes DM, Alton EW. Update on gene therapy for cystic fibrosis. Curr Opin Mol Ther 2003; 5: 489-494.
4. Montier T, Delepine P, Pichon C, Ferec C, Porteous DJ, Midoux P. Non-viral vectors in cystic fibrosis gene therapy: Progress and challenges. Trends Biotechnol 2004; 22: 586-592.
5. Cotton CU, Stutts MJ, Knowles MR, Gatzy JT, Boucher RC. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. J Clin Invest 1987; 79: 80-85.
6. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR et al. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005; 16: 2154-2167.
7. Puchelle E, Gaillard D, Ploton D, Hinnrasky J, Fuchey C, Boutterin MC et al. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 1992; 7: 485-491.
8. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992; 2: 240-248.
9. Harris A, McCarthy V. The CFTR gene and regulation of its expression. Pediatr Pulmonol 2005; 40: 1-8.
10. Yoshimura K, Rosenfeld MA, Nakamura H, Scherer EM, Pavirani A, Lecocq JP et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
11. Virella-Lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S et al. Enhancing rAAV vector expression in the lung. J Gene Med 2005; 7: 842-850.
12. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Therapy 2001; 8: 1539-1546.
13. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004; 23: 146-158.
14. Koehler DR, Hannam V, Belcastro R, Steer B, Wen Y, Post M et al. Targeting transgene expression for cystic fibrosis gene therapy. Mol Ther 2001; 4: 58-65.
15. Ostrowski LE, Hutchins JR, Zakel K, O'Neal WK. Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter. Mol Ther 2003; 8: 637-645.
16. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
17. Drumm ML, Pope HA, Cliff WH, Rommens JM, Marvin SA, Tsui LC et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990; 62: 1227-1233.
18. Mall M, Kreda SM, Mengos A, Jensen TJ, Hirtz S, Seydewitz HH et al. The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 2004; 126: 32-41.
19. Grubb BR, Paradiso AM, Boucher RC. Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol 1994; 267: C293-C300.
20. MacVinish LJ, Gill DR, Hyde SC, Mofford KA, Evans MJ, Higgins CF et al. Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10-CFTR2. J Physiol 1997; 499: 677-687.
21. Davidson DJ, Rolfe M. Mouse models of cystic fibrosis. Trends Genet 2001; 17: S29-S37.
22. Grubb BR, Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 1999; 79: S193-S214.
23. Rochelle LG, Li DC, Ye H, Lee E, Talbot CR, Boucher RC. Distribution of ion transport mRNAs throughout murine nose and lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L14-L24.
24. - secretion. Am J Physiol 1994; 266: L493-L501.
25. Mohler PJ, Kreda SM, Boucher RC, Sudol M, Stutts MJ, Milgram SL. Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50. J Cell Biol 1999; 147: 879-890.
26. Murphy DB, Seemann S, Wiese S, Kirschner R, Grzeschik KH, Thies U. The human hepatocyte nuclear factor 3/fork head gene FKHL13: Genomic structure and pattern of expression. Genomics 1997; 40: 462-469.
27. Pickles RJ. The development of paramyxovirus vectors for efficient delivery of CFTR to ciliated airway epithelium. Pediatr Pulmonol 2004; Suppl 27: 137-138.
28. Schmid A, Bai G, Schmid N, Zaccolo M, Ostrowski LE, Conner GE et al. Real-time analysis of cAMP-mediated regulation of ciliary motility in single primary human airway epithelial cells. J Cell Sci 2006; 119: 4176-4186.
29. Rawlins EL, Ostrowski LE, Randell SH, Hogan BL. Inaugural article: Lung development and repair: Contribution of the ciliated lineage. Proc Natl Acad Sci USA 2007; 104: 410-417.
30. Dorin JR, Dickinson P, Alton EW, Smith SN, Geddes DM, Stevenson BJ et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 1992; 359: 211-215.
31. Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther 2002; 5: 413-419.
32. Limberis M, Anson DS, Fuller M, Parsons DW. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther 2002; 13: 1961-1970.
33. Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
34. Parsons DW, Grubb BR, Johnson LG, Boucher RC. Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum Gene Ther 1998; 9 2661-2672.
35. Yorifuji T, Lemna WK, Ballard CF, Rosenbloom CL, Rozmahel R, Plavsic N et al. Molecular cloning and sequence analysis of the murine cDNA for the cystic fibrosis transmembrane conductance regulator. Genomics 1991; 10: 547-550.
36. Lansdell KA, Delaney SJ, Lunn DP, Thomson SA, Sheppard DN, Wainwright BJ. Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cla channels expressed in mammalian cells. J Physiol 1998; 508 (Part 2): 379-392.
37. Yan W, Samaha FF, Ramkumar M, Kleyman TR, Rubenstein RC. Cystic fibrosis transmembrane conductance regulator differentially regulates human and mouse epithelial sodium channels in Xenopus oocytes. J Biol Chem 2004; 279: 23183-23192.
38. Rozmahel R, Gyomorey K, Plyte S, Nguyen V, Wilschanski M, Durie P et al. Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA. Hum Mol Genet 1997; 6: 1153-1162.
39. Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 1994; 266: 1705-1708.
40. French PJ, van Doorninck JH, Peters RH, Verbeek E, Ameen NA, Marino CR et al. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J Clin Invest 1996; 98: 1304-1312.
41. Becq F, Mettey Y, Gray MA, Galietta LJ, Dormer RL, Merten M et al. Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel. J Biol Chem 1999; 274: 27415-27425.
42. Grubb BR, Rogers TD, Kulaga HM, Burns KA, Wonsetler RL, Reed RR et al. Olfactory epithelia exhibit progressive functional and morphological defects in CF mice. Am J Physiol Cell Physiol 2007 (in press).
43. Parsons DW, Hopkins PJ, Bourne AJ, Boucher RC, Martin AJ. Airway gene transfer in mouse nasal-airways: Importance of identification of epithelial type for assessment of gene transfer. Gene Therapy 2000; 7: 1810-1815.
44. Jiang C, Akita GY, Colledge WH, Ratcliff RA, Evans MJ, Hehir KM et al. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice. Hum Gene Ther 1997; 8 671-680.
45. Arimoto Y, Nagata H, Isegawa N, Kumahara K, Isoyama K, Konno A et al. In vivo expression of adenovirus-mediated lacZ gene in murine nasal mucosa. Acta Otolaryngol 2002; 122: 627-633.
46. Grubb BR. Bioelectric measurement of CFTR function in mice. Methods Mol Med 2002; 70: 525-535.